Trial Condition(s):

N/A

SD/MD study in Chinese,BAY1192631, ICPP

Bayer Identifier:

16411

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

N/A

Trial Dates

June2014

August2014

Phase

Could I receive a placebo?

Products

Sivextro (Tedizolid phosphate, BAY119-2631)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status
Locations Investigative Site Beijing, China, 100730	Status Completed		Contact Us: E-mail: [email protected] Phone: Not Available

Locations

Status

Locations

Investigative Site

Beijing, China, 100730

Status

Completed

Contact Us:

E-mail: [email protected]

Phone: Not Available

N/A

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

Trial Purpose

Key Participation Requirements

sex

age

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information